The primary investment objective of the scheme is to seek to generate continuous returns by investing in equity and equity related or fixed-income securities of Pharma and other associated companies.
Entry Load
nil
Exit Load
1
Value
As on
Latest NAV
Rs. 39.08
03/09/2010
Net Asset Size
Rs. 503.59 Crores
30/07/2010
Last Dividend
15.00%
31/08/2009
Assets Break-up (as on 30-07-2010)
%age
Equity
88.90
Cash
9.25
Others
1.85
Absolute Return (as on 03/09/2010)
1 Week
1 Month
3 Months
6 Months
9 Months
1 Year
1.13%
-0.19%
4.12%
17.14%
24.29%
64.24%
Mutual Fund
Registrar
11th floor & 12th floor, One Indiabulls Centre, Tower 1,
Jupiter Mills Compound 841, Senapati Bapat Marg,
Elphinstone Road, Mumbai, Maharashtra, India, 400013 Email: jignesh.pandya@relianceada.com Web: http://www.reliancemutual.com
Banks accept deposit money from investor’s with a promise to give them certain profit on their deposits. This money then invested into different instruments, where they get higher returns than what they have promised depositors…
Even in the new age Financial World Bond & FDs look attractive with regular intervals and it continues to be a part of every portfolio. We suggest investors when & which FD would give them better post tax yield…
Equity IPO’s have given huge returns to investors in the past. Every IPO Company has to be profitable for past 3 years and the same company’s valuations are analyzed and then it gets its deserving price band.
